Table 3

Follow-Up Outcomes

Follow-up time3.0 ± 1.6
Total patient-yrs276.6
Post-procedural DAPT for 6 months41.8% (41/98)
Post-procedural VKA and aspirin for 45 days58.2% (57/98)
Device-associated thrombus2.1% (2/96)
Stroke/TIA1.4%
Stroke0.7%
TIA0.7%
Intracranial hemorrhage1.1%
Total major bleeding complications2.1%
Deaths3.5%

Values are mean ± SD, % (n/N), or % per year.

DAPT = dual-antiplatelet therapy; TIA = transient ischemic attack; VKA = vitamin K antagonist.